Hyperbilirubinemia Management

Diagnosis and Laboratory Tests

• Conjugated bilirubin >20-30% of total bilirubin suggests liver disease, according to the American Gastroenterological Association 1
• For suspected Gilbert's syndrome, calculate proportion of conjugated bilirubin (should be <20-30% of total) 1
• The first step in evaluating hyperbilirubinemia is to determine if it is conjugated (direct) or unconjugated (indirect) 2
• A bilirubin level of 8 mg/dL requires further evaluation to determine if it is conjugated or unconjugated hyperbilirubinemia, as this distinction guides management and has significant implications for morbidity and mortality 2
• Complete history and physical examination, including assessing risk factors for liver disease, medication history, and signs of hepatic disease, are essential in evaluating hyperbilirubinemia 2
• Laboratory testing, such as liver function tests (ALT, AST, alkaline phosphatase), direct and indirect bilirubin fractions, complete blood count with peripheral smear, and coagulation studies (PT/INR, albumin), should be performed to assess liver function and identify underlying causes 2

• Important laboratory tests for diagnosing and managing neonatal jaundice include:

  | Test | Description | | --- | --- | | Blood type and Coombs' test | To identify blood group incompatibility | | Complete blood count and smear | To evaluate for hemolysis | | Direct or conjugated bilirubin measurement | To assess liver function | | Reticulocyte count and G6PD testing | To evaluate for G6PD deficiency | 3

• Imaging studies, including abdominal ultrasonography to evaluate for biliary obstruction, and potentially CT or MRI, may be necessary based on the clinical scenario 2
• Risk factors that require closer monitoring include jaundice appearing within the first 24 hours of life, rapid rise in bilirubin (≥0.3 mg/dL per hour in the first 24 hours or ≥0.2 mg/dL per hour thereafter), ABO or Rh incompatibility with positive DAT, and gestational age <38 weeks 4
• Other risk factors for neonatal jaundice include jaundice within the first 24 hours of life, blood group incompatibility (ABO, Rh), predischarge bilirubin level in high-risk zone, G6PD deficiency, and exclusive breastfeeding, as identified by the American Academy of Pediatrics 5

Management of Hyperbilirubinemia

• Initiate phototherapy based on hour-specific nomograms and risk factors, as recommended by the American Academy of Pediatrics 5
• Consider discontinuing phototherapy when total serum bilirubin falls below 13-14 mg/dL 5
• For patients with hemolytic diseases, follow-up bilirubin measurement within 24 hours after discharge is recommended 5
• Phototherapy is the primary intervention for severe indirect hyperbilirubinemia, with initiation based on hour-specific nomograms and risk factors, and lower thresholds for phototherapy intervention are recommended for G6PD-deficient infants and premature neonates, as recommended by the American Academy of Pediatrics 5
• Administer IVIG (0.5-1 g/kg over 2 hours) if TSB is rising despite intensive phototherapy or TSB is within 2-3 mg/dL of exchange transfusion level 5
• Exchange transfusion may be necessary for extreme hyperbilirubinemia not responding to phototherapy, but carries risks including apnea, bradycardia, cyanosis, thrombosis, and necrotizing enterocolitis 5, 6
• The American Academy of Pediatrics recommends phototherapy for infants >72 hours old when total serum bilirubin (TSB) reaches 17-20 mg/dL or higher, depending on risk factors 5
• Monitor TSB after starting phototherapy to verify efficacy, with repeat TSB measurements at specific intervals based on TSB levels 5, 4
• Repeat total serum bilirubin (TSB) measurement within 2-3 hours if TSB ≥ 25 mg/dL (428 μmol/L), within 3-4 hours if TSB 20-25 mg/dL (342-428 μmol/L), and in 4-6 hours if TSB < 20 mg/dL (342 μmol/L), as recommended by the American Academy of Pediatrics 5
• Consider discontinuing phototherapy when TSB has declined by 2-4 mg/dL below the hour-specific threshold at which it was initiated, and obtain follow-up TSB 8-12 hours after discontinuation of phototherapy and on the following day for infants with positive DAT who received phototherapy 4

Breastfeeding and Nutrition

• The American Academy of Pediatrics suggests encouraging breastfeeding 8-12 times per day to ensure adequate feeding 5
• Continue breastfeeding if possible during phototherapy, ensuring adequate hydration with breastfeeding every 2-3 hours, and consider supplementing with formula or expressed breast milk if weight loss >12% or clinical/biochemical evidence of dehydration 5

Special Considerations

• Persistent conjugated hyperbilirubinemia may indicate drug-induced liver injury or progressive liver disease 1
• Patients with decompensated cirrhosis have additional risks for increased morbidity and mortality if DILI occurs 1
• Avoid sunlight exposure as therapy due to practical difficulties and risk of sunburn, as advised by the American Academy of Pediatrics 5
• In children with elevated bilirubin, the management approach differs significantly from neonatal hyperbilirubinemia and should focus on identifying and treating the underlying cause rather than using phototherapy or exchange transfusion, as per the American Academy of Pediatrics guidelines 5
• The risk of bilirubin encephalopathy (kernicterus) is significantly lower in children beyond the neonatal period due to maturation of the blood-brain barrier 5
• Severe hyperbilirubinemia can lead to bilirubin encephalopathy, also known as kernicterus 5, 6
• Overtreatment in neonates with phototherapy has potential adverse effects, including interference with breastfeeding and maternal-infant bonding 6
• Undertreatment in high-risk neonates can lead to kernicterus and permanent neurological damage 5
• Parents should be educated on warning signs requiring immediate medical attention, including fever, poor feeding, lethargy, irritability, breathing difficulties, and color changes, as recommended by the American Academy of Pediatrics 7
• Risk assessment before discharge is essential for all newborns, especially for infants discharged before 72 hours of age, as recommended by the American Academy of Pediatrics 5